Aliases & Classifications for Pityriasis Rosea

MalaCards integrated aliases for Pityriasis Rosea:

Name: Pityriasis Rosea 12 42 14 69
Pityriasis Circinata 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8892
ICD10 33 L42
ICD9CM 35 696.3
MeSH 42 D017515
NCIt 47 C26855
SNOMED-CT 64 156373006 77252004
UMLS 69 C0032026

Summaries for Pityriasis Rosea

MalaCards based summary : Pityriasis Rosea, also known as pityriasis circinata, is related to rheumatoid arthritis and pityriasis rotunda. An important gene associated with Pityriasis Rosea is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways/superpathways are Innate Immune System and Class I MHC mediated antigen processing and presentation. The drugs Tacrolimus and Petrolatum have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and testes, and related phenotype is Increased shRNA abundance (Z-score > 2).

Wikipedia : 72 Pityriasis rosea is a skin rash. It is benign but may inflict substantial discomfort in certain cases.... more...

Related Diseases for Pityriasis Rosea

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 121)
id Related Disease Score Top Affiliating Genes
1 rheumatoid arthritis 28.7 HLA-B HLA-DQB1 HLA-DRB1 HLA-DRB5
2 pityriasis rotunda 11.4
3 migraine with brainstem aura 10.4 HLA-B HLA-DRB1
4 kernicterus due to isoimmunization 10.4 HLA-C HLA-DRB1
5 blood group incompatibility 10.4 HLA-C HLA-DRB1
6 fruit allergy 10.3 HLA-DQB1 HLA-DRB1
7 breast hemangiopericytoma 10.3 HLA-DQB1 HLA-DRB1
8 biemond syndrome 10.3 HLA-DQB1 HLA-DRB1
9 light chain deposition disease 10.3 HLA-DQB1 HLA-DRB1
10 juvenile sialidosis type 2 10.3 HLA-DQB1 HLA-DRB1
11 reese retinal dysplasia 10.3 HLA-DQB1 HLA-DRB1
12 mosaic trisomy 1 10.3 HLA-DQB1 HLA-DRB1
13 autoimmune retinopathy 10.3 HLA-DQB1 HLA-DRB1
14 myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr1 10.3 HLA-B HLA-DQB1
15 limb-body wall complex 10.3 HLA-DQB1 HLA-DRB1
16 transient retinal arterial occlusion 10.3 HLA-DQB1 HLA-DRB1
17 ovarian surface papilloma 10.3 HLA-DQB1 HLA-DRB1
18 pellagra like syndrome 10.3 HLA-DQB1 HLA-DRB1
19 clear cell adenocarcinoma of ovary 10.3 HLA-DQB1 HLA-DRB1
20 lymphocytic colitis 10.3 HLA-DQB1 HLA-DRB1
21 papillary squamous carcinoma 10.2 HLA-DQB1 HLA-DRB1
22 hanhart syndrome 10.2 HLA-DRB1 HLA-DRB4
23 reproductive system disease 10.2 HLA-DQB1 HLA-DRB1
24 oculogyric crisis 10.2 HLA-DQB1 HLA-DRB1
25 psoriasis 10.2
26 disease of mental health 10.2 HLA-B HLA-DRB1
27 muscle tissue disease 10.2 HLA-B HLA-C
28 infantile hypotonia 10.2 HLA-DQB1 HLA-DRB1
29 dermatitis 10.2
30 moderately severe hemophilia b 10.2 HLA-DQB1 HLA-DRB1
31 plummer's disease 10.1 HLA-DRB1 HLA-DRB5
32 hepatitis 10.1
33 epidermolysis bullosa simplex superficialis 10.1 HLA-DQB1 HLA-DRB1
34 autosomal recessive severe congenital neutropenia due to cxcr2 deficiency 10.1 HLA-A HLA-B
35 exanthem 10.1
36 syphilis 10.1
37 lichen planus 10.1
38 acute cholangitis 10.1 HLA-B HLA-C HLA-DRB1
39 cardioskeletal syndrome, kuwaiti type 10.1 HLA-A HLA-B
40 leprosy 4 10.1 HLA-B HLA-C HLA-DRB1
41 isthmus cancer 10.1 HLA-B HLA-DRB1
42 thrombotic thrombocytopenic purpura 10.0 HLA-A HLA-B
43 hepatitis b 10.0
44 erythema multiforme 10.0
45 hepatitis c 10.0
46 influenza 10.0
47 herpes zoster 10.0
48 gianotti crosti syndrome 10.0
49 hemangioma-thrombocytopenia syndrome 10.0 HLA-A HLA-C
50 idiopathic subglottic tracheal stenosis 9.9 HLA-B HLA-DQB1 HLA-DRB1

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to Pityriasis Rosea

Symptoms & Phenotypes for Pityriasis Rosea

GenomeRNAi Phenotypes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 10.82 HLA-A HLA-C HLA-B
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 10.82 HLA-A HLA-C HLA-B
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 10.82 HLA-A HLA-C HLA-B
4 Increased shRNA abundance (Z-score > 2) GR00366-A-12 10.82 HLA-DRB4
5 Increased shRNA abundance (Z-score > 2) GR00366-A-124 10.82 HLA-C
6 Increased shRNA abundance (Z-score > 2) GR00366-A-127 10.82 HLA-DRB4
7 Increased shRNA abundance (Z-score > 2) GR00366-A-130 10.82 HLA-DRB4
8 Increased shRNA abundance (Z-score > 2) GR00366-A-137 10.82 HLA-DRB4
9 Increased shRNA abundance (Z-score > 2) GR00366-A-149 10.82 HLA-C
10 Increased shRNA abundance (Z-score > 2) GR00366-A-156 10.82 HLA-A HLA-C HLA-B
11 Increased shRNA abundance (Z-score > 2) GR00366-A-162 10.82 HLA-C
12 Increased shRNA abundance (Z-score > 2) GR00366-A-174 10.82 HLA-DRB4
13 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.82 HLA-DRB5
14 Increased shRNA abundance (Z-score > 2) GR00366-A-177 10.82 HLA-DRB4 HLA-DRB5
15 Increased shRNA abundance (Z-score > 2) GR00366-A-178 10.82 HLA-A HLA-C HLA-B HLA-DRB5
16 Increased shRNA abundance (Z-score > 2) GR00366-A-185 10.82 HLA-DRB4
17 Increased shRNA abundance (Z-score > 2) GR00366-A-19 10.82 HLA-A HLA-C HLA-B
18 Increased shRNA abundance (Z-score > 2) GR00366-A-196 10.82 HLA-DRB4
19 Increased shRNA abundance (Z-score > 2) GR00366-A-2 10.82 HLA-DRB4
20 Increased shRNA abundance (Z-score > 2) GR00366-A-202 10.82 HLA-C
21 Increased shRNA abundance (Z-score > 2) GR00366-A-31 10.82 HLA-A HLA-C HLA-DRB4 HLA-B
22 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.82 HLA-DRB4
23 Increased shRNA abundance (Z-score > 2) GR00366-A-46 10.82 HLA-DRB4
24 Increased shRNA abundance (Z-score > 2) GR00366-A-47 10.82 HLA-C
25 Increased shRNA abundance (Z-score > 2) GR00366-A-67 10.82 HLA-DRB4
26 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.82 HLA-A HLA-C HLA-B
27 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.82 HLA-DRB4
28 Increased shRNA abundance (Z-score > 2) GR00366-A-74 10.82 HLA-A HLA-C HLA-B
29 Increased shRNA abundance (Z-score > 2) GR00366-A-81 10.82 HLA-DRB5
30 Increased shRNA abundance (Z-score > 2) GR00366-A-93 10.82 HLA-C

Drugs & Therapeutics for Pityriasis Rosea

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
2
Petrolatum Approved Phase 4 8009-03-8
3
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
4
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
5 Micronutrients Phase 4
6 Dermatologic Agents Phase 4
7 Trace Elements Phase 4
8 Vasoconstrictor Agents Phase 4
9 Emollients Phase 4
10 Vitamins Phase 4
11 Immunosuppressive Agents Phase 4
12 Bone Density Conservation Agents Phase 4
13 Calcineurin Inhibitors Phase 4
14 Calcium, Dietary Phase 4

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba Completed NCT01388517 Phase 4 Tacrolimus;Calcitriol;Petrolatum

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

Anatomical Context for Pityriasis Rosea

MalaCards organs/tissues related to Pityriasis Rosea:

39
Skin, Bone, Testes, Tongue, T Cells, Myeloid, Bone Marrow

Publications for Pityriasis Rosea

Articles related to Pityriasis Rosea:

(show top 50) (show all 421)
id Title Authors Year
1
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects - A Reply. ( 28216734 )
2017
2
Persistent and Generalized Purpuric Lesions in an Adolescent: A Rare Atypical Form of Pityriasis Rosea. ( 28584764 )
2017
3
Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus. ( 28670260 )
2017
4
Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? ( 28764276 )
2017
5
Clinical variants of pityriasis rosea. ( 28685133 )
2017
6
Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic. ( 28203625 )
2017
7
Diagnosis and management of pityriasis rosea. ( 28002142 )
2017
8
Oropharyngeal lesions in pityriasis rosea. ( 28728872 )
2017
9
A retrospective study on rapid plasma reagin testing in patients with Pityriasis rosea. ( 28345391 )
2017
10
The role of interleukin-22 in pityriasis rosea. ( 27862158 )
2017
11
The role of dermoscopy using a triple light source in the diagnosis of pityriasis rosea: an observational pilot study. ( 28188635 )
2017
12
Concurrent pityriasis rosea and Bell's palsy. ( 28115404 )
2017
13
Pityriasis, Rosea ( 28846360 )
2017
14
Pityriasis rosea-like eruption induced by isotretinoin. ( 28359163 )
2017
15
Unique clinical presentations of pityriasis rosea: aphthous ulcers, vesicles and inverse distribution of lesions. ( 28329497 )
2017
16
Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea. ( 28192646 )
2017
17
Atypical pityriasis rosea: clinical evaluation of 27 patients. ( 27558764 )
2016
18
Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn. ( 27648382 )
2016
19
A position statement on the management of patients with pityriasis rosea. ( 27406919 )
2016
20
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. ( 26678150 )
2016
21
A Herald Patch Almost Encircling the Trunk-Extreme Pityriasis Rosea Gigantea in a Young Child. ( 27396667 )
2016
22
Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? ( 27103975 )
2016
23
Pityriasis rosea along Blaschko's lines: A rare variant. ( 27852994 )
2016
24
Pityriasis rosea: a natural history of pediatric cases in theCentral Anatolia Region of Turkey. ( 28081320 )
2016
25
Salute sign: A nonambiguous histopathological sign in pityriasis rosea. ( 27990399 )
2016
26
A case series of erythema multiforme-like pityriasis rosea. ( 27294066 )
2016
27
Atypical Pityriasis Rosea with Unilateral Presentation. ( 28208986 )
2016
28
Red Cell Distribution Width and Mean Platelet Volume in Patients With Pityriasis Rosea. ( 27222672 )
2016
29
Pityriasis Rosea: A Comprehensive Classification. ( 27096928 )
2016
30
Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. ( 27212277 )
2016
31
Is a treatment for pityriasis rosea really needed? ( 27730050 )
2016
32
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. ( 27512182 )
2016
33
Is There a Link between Human Herpesvirus Infection and Toll-like Receptors in the Pathogenesis of Pityriasis Rosea? A Case-control Study. ( 28128079 )
2016
34
A Case-Control Study on the Take-Off Sign in Lesional Skin Biopsies of Patients with Pityriasis Rosea. ( 28855934 )
2016
35
Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women. ( 28128088 )
2016
36
The Oxidant and Antioxidant Status in Pityriasis Rosea. ( 26955119 )
2016
37
Anesthetic Considerations for Neuraxial Anesthesia in Pregnant Patients With Pityriasis Rosea With Skin Lesions Covering the Lumbar Spine. ( 27513966 )
2016
38
Nomenclature of drug-induced pityriasis rosea-like rashes. ( 26491333 )
2015
39
Narrowband UVB phototherapy in pityriasis rosea. ( 26500862 )
2015
40
Author's Response--The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. ( 25566901 )
2015
41
Pityriasis rosea-like cutaneous eruption as the presenting symptom of Hodgkin lymphoma. Case report and review of the literature. ( 26512305 )
2015
42
Pityriasis rosea following human papillomavirus vaccination. ( 25527111 )
2015
43
Segmental pityriasis rosea within the area of BRAF-mutated metastatic melanoma. ( 26446380 )
2015
44
Pigmentogenes Pityriasis Rosea. ( 26584426 )
2015
45
Pityriasis rosea. ( 26514823 )
2015
46
Terbinafine induced pityriasis rosea-like eruption. ( 26729964 )
2015
47
Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. ( 25612842 )
2015
48
The efficacy of macrolides and acyclovir in pityriasis rosea. ( 25566900 )
2015
49
Pityriasis rosea-like adverse reaction to atenolol. ( 25791321 )
2015
50
Facial involvement in Pityriasis Rosea. ( 26584310 )
2015

Variations for Pityriasis Rosea

Expression for Pityriasis Rosea

Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for Pityriasis Rosea

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 35)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.77 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
2
Show member pathways
13.25 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
3
Show member pathways
13.15 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
4
Show member pathways
12.95 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
5
Show member pathways
12.81 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
6
Show member pathways
12.72 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7
Show member pathways
12.69 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
8
Show member pathways
12.6 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
9
Show member pathways
12.49 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
10
Show member pathways
12.46 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
11
Show member pathways
12.36 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
12
Show member pathways
12.32 HLA-A HLA-B HLA-C
13
Show member pathways
12.3 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
14
Show member pathways
12.28 HLA-A HLA-B HLA-C
15
Show member pathways
12.26 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
16 12.25 HLA-A HLA-B HLA-C
17 12.21 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
18
Show member pathways
12.18 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
19 12.15 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
20 12.13 HLA-A HLA-B HLA-C
21
Show member pathways
12.13 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
22
Show member pathways
12.02 HLA-A HLA-B HLA-C
23 12.01 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
24 11.95 HLA-A HLA-B HLA-C
25
Show member pathways
11.91 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
26 11.87 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
27 11.86 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
28 11.84 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
29 11.79 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
30
Show member pathways
11.72 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
31 11.68 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
32 11.66 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
33 11.53 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
34 11.33 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
35 11.15 HLA-A HLA-B HLA-C

GO Terms for Pityriasis Rosea

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 19)
id Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.96 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
2 Golgi apparatus GO:0005794 9.95 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
3 cell surface GO:0009986 9.87 HLA-A HLA-B HLA-C HLA-DRB1
4 lysosomal membrane GO:0005765 9.8 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
5 endosome membrane GO:0010008 9.76 HLA-DQB1 HLA-DRB1 HLA-DRB5
6 trans-Golgi network membrane GO:0032588 9.76 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7 early endosome membrane GO:0031901 9.71 HLA-A HLA-B HLA-C
8 endocytic vesicle membrane GO:0030666 9.71 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
9 late endosome membrane GO:0031902 9.7 HLA-DRB1 HLA-DRB4 HLA-DRB5
10 Golgi membrane GO:0000139 9.7 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
11 phagocytic vesicle membrane GO:0030670 9.69 HLA-A HLA-B HLA-C
12 transport vesicle membrane GO:0030658 9.67 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
13 recycling endosome membrane GO:0055038 9.65 HLA-A HLA-B HLA-C
14 clathrin-coated endocytic vesicle membrane GO:0030669 9.62 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
15 MHC class I protein complex GO:0042612 9.61 HLA-A HLA-B HLA-C
16 MHC class II protein complex GO:0042613 9.56 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
17 ER to Golgi transport vesicle membrane GO:0012507 9.5 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
18 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.17 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
19 plasma membrane GO:0005886 10.12 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 17)
id Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.88 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
2 viral process GO:0016032 9.86 HLA-A HLA-B HLA-C HLA-DRB1
3 regulation of immune response GO:0050776 9.74 HLA-A HLA-B HLA-C
4 T cell receptor signaling pathway GO:0050852 9.73 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
5 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.72 HLA-A HLA-B HLA-C
6 antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886 9.71 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7 type I interferon signaling pathway GO:0060337 9.69 HLA-A HLA-B HLA-C
8 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.63 HLA-A HLA-B HLA-C
9 immune response GO:0006955 9.63 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
10 T cell costimulation GO:0031295 9.62 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
11 humoral immune response mediated by circulating immunoglobulin GO:0002455 9.54 HLA-DQB1 HLA-DRB1
12 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002504 9.54 HLA-DQB1 HLA-DRB1 HLA-DRB5
13 protection from natural killer cell mediated cytotoxicity GO:0042270 9.52 HLA-A HLA-B
14 immunoglobulin production involved in immunoglobulin mediated immune response GO:0002381 9.49 HLA-DQB1 HLA-DRB1
15 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.43 HLA-A HLA-B HLA-C
16 antigen processing and presentation GO:0019882 9.43 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
17 interferon-gamma-mediated signaling pathway GO:0060333 9.17 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 9.33 HLA-A HLA-B HLA-C
2 peptide antigen binding GO:0042605 9.1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
3 MHC class II receptor activity GO:0032395 8.96 HLA-DQB1 HLA-DRB1

Sources for Pityriasis Rosea

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....